Last week CNN published an investigative report that concluded that Avanir Pharmaceuticals was paying physicians to prescribe its drug, Neudexta, to Alzheimer’s patients under the pretext that these patients have a rare disease. CNN’s research revealed a 400% increase in the sale of Neudexta in the past four years, and Read More…
STAT, the on-line health publication covering medicine, science and health issues, recently sponsored an hour on-line “chat” with Reisa Sperling, the head of the Center for Alzheimer’s Research and Treatment at Brigham & Women’s Hospital. Dr. Sperling answered questions about the state of Alzheimer research and STAT reporters filled out Read More…
Over 50% of people over the age of 70 have a hearing impairment. Left untreated, the loss results in social isolation, lack of intellectual stimulation, Read More…
Millions of dollars are being spent on research efforts to find a treatment for Alzheimer’s disease. These efforts are hampered by the inability to definitively identify who has early stage Alzheimer’s disease, or who might be Read More…
Last week the New York Attorney General and the Federal Trade Commission jointly filed a lawsuit against Quincy Biosciences, the maker of Prevagen, charging that its claims that Prevagen improves memory are false and deceptive.
How Prevagen Read More…
